Publication Information

{'id': 'https://openalex.org/W4282976784', 'doi': 'https://doi.org/10.1158/1538-7445.am2022-2866', 'title': 'Abstract 2866: BAY 3375968: An afucosylated anti-CCR8 antibody depleting activated intratumoral regulatory T cells as a cancer immunotherapy', 'display_name': 'Abstract 2866: BAY 3375968: An afucosylated anti-CCR8 antibody depleting activated intratumoral regulatory T cells as a cancer immunotherapy', 'publication_year': 2022, 'publication_date': '2022-06-15', 'ids': {'openalex': 'https://openalex.org/W4282976784', 'doi': 'https://doi.org/10.1158/1538-7445.am2022-2866'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2022-2866', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5047866999', 'display_name': 'Helge G. Roider', 'orcid': 'https://orcid.org/0000-0002-4614-5219'}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Helge Roider', 'raw_affiliation_strings': ['1Bayer AG, Berlin, Germany.'], 'affiliations': [{'raw_affiliation_string': '1Bayer AG, Berlin, Germany.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5013008114', 'display_name': 'Su-Yi Tseng', 'orcid': None}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Su-Yi Tseng', 'raw_affiliation_strings': ['1Bayer AG, Berlin, Germany.'], 'affiliations': [{'raw_affiliation_string': '1Bayer AG, Berlin, Germany.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5066729294', 'display_name': 'Sabine Hoff', 'orcid': None}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Sabine Hoff', 'raw_affiliation_strings': ['1Bayer AG, Berlin, Germany.'], 'affiliations': [{'raw_affiliation_string': '1Bayer AG, Berlin, Germany.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5061581322', 'display_name': 'Sandra Berndt', 'orcid': 'https://orcid.org/0000-0002-9732-9413'}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Sandra Berndt', 'raw_affiliation_strings': ['1Bayer AG, Berlin, Germany.'], 'affiliations': [{'raw_affiliation_string': '1Bayer AG, Berlin, Germany.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045780011', 'display_name': 'Katharina Filarski', 'orcid': None}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Katharina Filarski', 'raw_affiliation_strings': ['1Bayer AG, Berlin, Germany.'], 'affiliations': [{'raw_affiliation_string': '1Bayer AG, Berlin, Germany.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5010386744', 'display_name': 'Uwe Gritzan', 'orcid': None}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Uwe Gritzan', 'raw_affiliation_strings': ['1Bayer AG, Berlin, Germany.'], 'affiliations': [{'raw_affiliation_string': '1Bayer AG, Berlin, Germany.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040976235', 'display_name': 'Beatrix Stelte‐Ludwig', 'orcid': 'https://orcid.org/0000-0002-1045-1134'}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Beatrix Stelte-Ludwig', 'raw_affiliation_strings': ['1Bayer AG, Berlin, Germany.'], 'affiliations': [{'raw_affiliation_string': '1Bayer AG, Berlin, Germany.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043125514', 'display_name': 'Wiebke Nadler', 'orcid': 'https://orcid.org/0000-0002-7673-1147'}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Wiebke M. Nadler', 'raw_affiliation_strings': ['1Bayer AG, Berlin, Germany.'], 'affiliations': [{'raw_affiliation_string': '1Bayer AG, Berlin, Germany.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5074766062', 'display_name': 'Joanna Grudzinska‐Goebel', 'orcid': None}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Joanna Grudzinska-Goebel', 'raw_affiliation_strings': ['1Bayer AG, Berlin, Germany.'], 'affiliations': [{'raw_affiliation_string': '1Bayer AG, Berlin, Germany.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5013639434', 'display_name': 'P. Ellinger', 'orcid': None}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Philipp Ellinger', 'raw_affiliation_strings': ['1Bayer AG, Berlin, Germany.'], 'affiliations': [{'raw_affiliation_string': '1Bayer AG, Berlin, Germany.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5018813375', 'display_name': 'Mark Trautwein', 'orcid': None}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Mark Trautwein', 'raw_affiliation_strings': ['1Bayer AG, Berlin, Germany.'], 'affiliations': [{'raw_affiliation_string': '1Bayer AG, Berlin, Germany.', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5067338320', 'display_name': 'Mátyás Gorjánácz', 'orcid': 'https://orcid.org/0000-0002-8398-410X'}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Matyas Gorjanacz', 'raw_affiliation_strings': ['1Bayer AG, Berlin, Germany.'], 'affiliations': [{'raw_affiliation_string': '1Bayer AG, Berlin, Germany.', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 62}, 'biblio': {'volume': '82', 'issue': '12_Supplement', 'first_page': '2866', 'last_page': '2866'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy', 'score': 0.9934, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy', 'score': 0.9934, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10580', 'display_name': 'Immunobiology of Dendritic Cells', 'score': 0.9934, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11491', 'display_name': 'Chimeric Antigen Receptor T Cell Therapy', 'score': 0.9923, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/tumor-microenvironment', 'display_name': 'Tumor Microenvironment', 'score': 0.519007}, {'id': 'https://openalex.org/keywords/cancer-immunotherapy', 'display_name': 'Cancer immunotherapy', 'score': 0.5121286}, {'id': 'https://openalex.org/keywords/t-cell-therapy', 'display_name': 'T Cell Therapy', 'score': 0.510385}, {'id': 'https://openalex.org/keywords/car-t-cells', 'display_name': 'CAR T Cells', 'score': 0.50684}, {'id': 'https://openalex.org/keywords/biomarkers-for-immunotherapy', 'display_name': 'Biomarkers for Immunotherapy', 'score': 0.504913}, {'id': 'https://openalex.org/keywords/tumor-antigen', 'display_name': 'Tumor Antigen', 'score': 0.502386}], 'concepts': [{'id': 'https://openalex.org/C40677261', 'wikidata': 'https://www.wikidata.org/wiki/Q21418091', 'display_name': 'Antibody-dependent cell-mediated cytotoxicity', 'level': 4, 'score': 0.56995386}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.5599138}, {'id': 'https://openalex.org/C2776107976', 'wikidata': 'https://www.wikidata.org/wiki/Q1786433', 'display_name': 'Tumor microenvironment', 'level': 3, 'score': 0.53952986}, {'id': 'https://openalex.org/C2780674031', 'wikidata': 'https://www.wikidata.org/wiki/Q2012719', 'display_name': 'Cancer immunotherapy', 'level': 4, 'score': 0.5121286}, {'id': 'https://openalex.org/C8891405', 'wikidata': 'https://www.wikidata.org/wiki/Q1059', 'display_name': 'Immune system', 'level': 2, 'score': 0.50680596}, {'id': 'https://openalex.org/C2777701055', 'wikidata': 'https://www.wikidata.org/wiki/Q1427096', 'display_name': 'Immunotherapy', 'level': 3, 'score': 0.50160694}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.4975908}, {'id': 'https://openalex.org/C159654299', 'wikidata': 'https://www.wikidata.org/wiki/Q79460', 'display_name': 'Antibody', 'level': 2, 'score': 0.45734262}, {'id': 'https://openalex.org/C154317977', 'wikidata': 'https://www.wikidata.org/wiki/Q376266', 'display_name': 'Cytotoxic T cell', 'level': 3, 'score': 0.44373295}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.41886568}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.4100047}, {'id': 'https://openalex.org/C542903549', 'wikidata': 'https://www.wikidata.org/wiki/Q422248', 'display_name': 'Monoclonal antibody', 'level': 3, 'score': 0.35495389}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.1498923}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2022-2866', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'No poverty', 'id': 'https://metadata.un.org/sdg/1', 'score': 0.46}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4322720888', 'https://openalex.org/W4296613612', 'https://openalex.org/W4200022043', 'https://openalex.org/W3193904228', 'https://openalex.org/W3185708072', 'https://openalex.org/W3111580887', 'https://openalex.org/W2902626376', 'https://openalex.org/W2893846263', 'https://openalex.org/W2884525857', 'https://openalex.org/W2112727616'], 'abstract_inverted_index': {'Abstract': [0], 'Regulatory': [1], 'T': [2, 30, 84, 215, 344], 'cells': [3, 31, 345], '(Tregs)': [4], 'play': [5], 'an': [6], 'indispensable': [7], 'role': [8], 'in': [9, 32, 167, 240], 'mediating': [10], 'peripheral': [11, 80, 148], 'tolerance': [12], 'to': [13, 141, 255, 272], 'self-antigens.': [14], 'They': [15], 'can': [16], 'also': [17, 234], 'promote': [18], 'tumor': [19, 34, 58, 112, 120, 203], 'growth': [20], 'by': [21, 228], 'suppressing': [22], 'the': [23, 33, 44, 49, 99, 139, 281, 293, 354], 'function': [24], 'of': [25, 43, 51, 201, 208, 221, 302, 353], 'effector': [26, 83], 'CD8+': [27, 214], 'and': [28, 68, 82, 97, 102, 114, 180, 213, 253, 268, 298], 'CD4+': [29], 'microenvironment': [35], '(TME).': [36], 'Furthermore,': [37], 'Tregs': [38, 76, 81, 96, 107, 145, 149, 173], 'are': [39, 108, 305], 'identified': [40], 'as': [41, 123, 346], 'one': [42], 'key': [45], 'resistance': [46], 'mechanisms': [47], 'hampering': [48], 'efficacy': [50, 188, 197, 220, 269], 'immune': [52, 152], 'checkpoint': [53], 'inhibitors': [54], '(ICIs)': [55], 'across': [56, 118, 198], 'many': [57, 119], 'types.': [59], 'Therefore,': [60], 'there': [61], 'is': [62, 90, 156, 246], 'a': [63, 157, 199, 236, 247, 287, 347], 'high': [64, 111], 'need': [65], 'for': [66, 286, 357], 'safe': [67], 'effective': [69], 'agents': [70], 'that': [71], 'would': [72], 'specifically': [73, 142], 'deplete': [74, 143], 'tumor-infiltrating': [75, 95], 'while': [77], 'sparing': [78], 'both': [79], 'cells.': [85, 153], 'Chemokine': [86], 'receptor': [87], '8': [88], '(CCR8)': [89], 'predominantly': [91], 'expressed': [92], 'on': [93, 280], 'activated': [94, 341], 'marks': [98], 'most': [100], 'suppressive': [101], 'proliferative': [103], 'Treg': [104, 211, 249, 276], 'population.': [105], 'CCR8+': [106, 172, 210], 'associated': [109], 'with': [110, 205, 230], 'grade': [113], 'poor': [115], 'overall': [116], 'survival': [117], 'types': [121], 'such': [122], 'lung,': [124], 'breast,': [125], 'or': [126, 150], 'head-neck': [127], 'cancer.': [128], 'Thus,': [129], 'unlike': [130], 'other': [131, 151, 273], 'approaches': [132], 'directed': [133], 'against': [134], 'Tregs,': [135], 'targeting': [136, 277], 'CCR8': [137, 222, 245], 'offers': [138], 'opportunity': [140], 'intra-tumoral': [144], 'without': [146], 'impacting': [147], 'BAY': [154, 232, 261, 303, 334], '3375968': [155, 233, 262, 304], 'non-internalizing': [158], 'fully': [159], 'human': [160, 171], 'glycoengineered': [161], '(afucosylated)': [162], 'monoclonal': [163], 'IgG1': [164], 'antibody,': [165], 'which': [166], 'vitro': [168], 'selectively': [169], 'depleted': [170], 'via': [174], 'antibody': [175, 181, 339], 'dependent': [176, 182], 'cellular': [177, 183], 'cytotoxicity': [178], '(ADCC)': [179], 'phagocytosis': [184], '(ADCP).': [185], 'In': [186, 243], 'vivo': [187], 'studies': [189], 'using': [190], 'mouse': [191], 'surrogate': [192], 'antibodies': [193, 224], 'showed': [194, 235], 'strong': [195], 'monotherapeutic': [196, 219], 'variety': [200], 'murine': [202], 'models': [204], 'clear': [206], 'correlation': [207], 'intratumoral': [209, 342], 'depletion': [212], 'cell': [216], 'increase.': [217], 'The': [218], 'depleting': [223, 250, 340], 'was': [225], 'further': [226], 'enhanced': [227], 'combinations': [229], 'ICIs.': [231], 'good': [237], 'safety': [238, 267], 'profile': [239, 270], 'cynomolgus': [241], 'monkeys.': [242], 'conclusion,': [244], 'novel': [248], 'immunotherapy': [251, 349], 'target,': [252], 'due': [254], 'its': [256], 'highly': [257], 'tumor-restricted': [258], 'expression': [259], 'profile,': [260], 'may': [263], 'provide': [264], 'superior': [265], 'clinical': [266, 290], 'comparing': [271], 'less': [274], 'specific': [275], 'approaches.': [278], 'Based': [279], 'promising': [282], 'pre-clinical': [283], 'data,': [284], 'preparations': [285], 'phase': [288], 'I': [289], 'trial': [291], 'investigating': [292], 'safety,': [294], 'tolerability,': [295], 'pharmacokinetics,': [296], 'pharmacodynamics,': [297], 'preliminary': [299], 'anti-tumor': [300], 'activity': [301], 'underway.': [306], 'Citation': [307], 'Format:': [308], 'Helge': [309], 'Roider,': [310], 'Su-Yi': [311], 'Tseng,': [312], 'Sabine': [313], 'Hoff,': [314], 'Sandra': [315], 'Berndt,': [316], 'Katharina': [317], 'Filarski,': [318], 'Uwe': [319], 'Gritzan,': [320], 'Beatrix': [321], 'Stelte-Ludwig,': [322], 'Wiebke': [323], 'M.': [324], 'Nadler,': [325], 'Joanna': [326], 'Grudzinska-Goebel,': [327], 'Philipp': [328], 'Ellinger,': [329], 'Mark': [330], 'Trautwein,': [331], 'Matyas': [332], 'Gorjanacz.': [333], '3375968:': [335], 'An': [336], 'afucosylated': [337], 'anti-CCR8': [338], 'regulatory': [343], 'cancer': [348], '[abstract].': [350], 'In:': [351], 'Proceedings': [352], 'American': [355], 'Association': [356], 'Cancer': [358, 369], 'Research': [359], 'Annual': [360], 'Meeting': [361], '2022;': [362], '2022': [363], 'Apr': [364], '8-13.': [365], 'Philadelphia': [366], '(PA):': [367], 'AACR;': [368], 'Res': [370], '2022;82(12_Suppl):Abstract': [371], 'nr': [372], '2866.': [373]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4282976784', 'counts_by_year': [], 'updated_date': '2024-09-24T05:05:45.541446', 'created_date': '2022-06-17'}